NCT00006472 - Combination Chemotherapy Plus Radiation Therapy Followed By Surgery in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2000

Primary Completion Date

November 15, 2001

Study Completion Date

September 10, 2002

Conditions

Esophageal Cancer

Interventions

DRUG

carboplatin

Carboplatin AUC 6 days 1 and 22

DRUG

fluorouracil

5FU 225mg/m2 continuous infusion on days 1-42 during radiation

DRUG

paclitaxel

taxol

PROCEDURE

conventional surgery

RADIATION

radiation therapy

The initial fields should be treated AP:PA when possible to a dose of 4500 cGy in 180 cGy fractions

Trial Locations (6)

Washington Cancer Institute, Washington D.C.

Washington Hospital Center, Washington D.C.

Union Memorial Hospital, Baltimore

Harbor Hospital Center, Baltimore

Franklin Square Hospital Center, Baltimore

Good Samaritan Hospital of Maryland, Baltimore